Hoffmann-La Roche awarded general media-buying duties for fat-fighting drug Xenical to Media Marketing Solutions, New York, which also retained influenza drug Tamiflu, according to Loretta Volpe, president-CEO of the shop. Combined, the accounts are estimated at $50 million. Media Marketing is a small agency owned by Young & Rubicam that handles accounts that its Media Edge unit cannot. Lowe
Lintas & Partners Worldwide, New York, handled media for Xenical's launch.
Copyright October 2000, Crain Communications Inc.